Last updated on December 2019

A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)


Brief description of study

A randomized placebo-controlled trial to evaluate the safety and efficacy of three doses of study drug LY3154207 treated for 12 weeks in participants with mild-to-moderate dementia associated with LBD (PDD or DLB).

Clinical Study Identifier: NCT03305809

Find a site near you

Start Over

University of Puerto Rico

San Juan, Puerto Rico
6.82miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »

Santa Cruz Behavioral PSC

Bayamón, Puerto Rico
8.8miles
  Connect »